Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

ACI "Paragraph IV Disputes" Conference, San Francisco, December 8-9

By Aaron Barkoff

American Conference Institute will hold its popular "Paragraph IV Disputes" conference in San Francisco on December 8th and 9th.

Paul Berghoff, one of the founding partners of McDonnell Boehnen Hulbert & Berghoff LLP, will be presenting a talk entitled, "Let the Games Begin: The Start of the Paragraph IV Lawsuit--Pleadings and Considerations."  The rest of the agenda includes many other interesting topics:

• Pre-Suit Due Diligence Strategies in Anticipation of the Paragraph IV Challenge
• Assessing the ANDA Applicant's Initial Obligations
• New Takes on Obviousness: Pre-Suit Considerations for Brand-Names and Generics
• Throwing Down the Gauntlet: The Paragraph IV Notice Letter--Delivery and Receipt
• Exploring Exclusivity and Forfeiture Dilemmas Relative to Paragraph IV Litigation
• A Closer Look at Generic v. Generic Law Suits
• Litigating with Multiple ANDA Filers: Brand Name and Generic Perspectives
• FTC Keynote: Pay for Delay Settlements
• Recent Decisions Impacting Paragraph IV Challenges and Motion Practice
• Discovery Strategies and Pre-Trial Maneuvering Tactics for Brand Names and Generics
• Assessing Danger and Mitigating Liabilities Associated with Injunctions and "At Risk Launches"

In addition, there will be a pre-conference workshop on December 7th, entitled "Hatch-Waxman and BPCIA 101: A Primer on IP Basics and Regulatory Fundamentals," and a post-conference workshop on December 10th, entitled "The Master Class on Settling Paragraph IV Disputes: Brand-Name and Generic Perspectives."

ACI offers Orange Book Blog readers discounted registration: use discount code OBB to save $400.  For more information or to register, please visit the conference website.

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on November 12, 2010 (boomark / email).